Role of Faecal Calprotectin in Patients With Abdominal Pain

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

146 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-07-01

Study Completion Date

2023-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The evaluation of patients with abdominal pain is a challenge for the emergency physician and the selection of patients for second-level radiological examinations or endoscopic procedures is not always easy to perform. Faecal calprotectin could be a useful diagnostic marker to distinguish between "organic" or "functional" form and its determination could be helpful to select patients for further examinations, in the context of emergency setting.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Role of Polymerase Chain Reaction in the Management of Patients With Infective Endocarditis

NCT05791357

Endocarditis Infective

COMPLETED NA

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Gastrointestinal Diseases

NCT04698148

Clostridium Difficile Infection Multi Drug Resistant Organisms Chronic Inflammatory Bowel Disease +2 more

COMPLETED

Establishment of the Human Intestinal and Salivary Microbiota Biobank - Kidney Diseases

NCT04689074

Autosomal Dominant Polycystic Kidney Disease (ADPKD) Advanced-Chronic Kidney Disease (CKD) Diabetic Kidney Disease (DKD) +1 more

COMPLETED

Gut Microbiota in Patients With Peripheral Arterial Disease and Chronic Limb-threatening Ischemia

NCT05757297

Peripheral Arterial Disease

NOT_YET_RECRUITING

Immunohistology in USDD and Correlation Between Bacterial Flora and Phlogosis

NCT02068482

Diverticular Disease

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Inflammation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

abdominal pain

patients with abdominal pain

calprotectin levels

Intervention Type DIAGNOSTIC_TEST

dosage of calprotectin levels in patients with abdominal pain

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

calprotectin levels

dosage of calprotectin levels in patients with abdominal pain

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients with abdominal pain and/or diarrhea and/or rectal bleeding

Exclusion Criteria

* patients with age \< 18 years
* pregnant women;
* patients with oncological, cardiological, nephrological terminal diseases;
* patients on antibiotic therapy or who have taken it during the last month;
* patients with a history of colic resection or gastrointestinal surgery;
* patients with a previous diagnosis of inflammatory bowel disease (Crohn's disease, ulcerative colitis)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No